针对类风湿性关节炎的基于纳米粒子的治疗方法的新兴模式:跨越二十年的综合文献计量和视觉分析
Shenwei Xie1, Pan Liao1, Shuang Mi2
1Department of Rheumatology and Immunology, Hunan University of Medicine General Hospital, HuaiHua, 418000, China.
Open life sciences
|March 25, 2025
概括
对于类风湿性关节炎 (RA) 治疗的纳米粒子系统的研究正在迅速增长. 关键领域包括药物输送,黄金纳米粒子和智能系统,中国在全球出版物中处于领先地位.
科学领域:
- 纳米医学是一种纳米医学.
- 类风湿病学 类风湿病学
- 生物技术是生物技术.
背景情况:
- 类风湿性关节炎 (RA) 是一种慢性自身免疫性疾病,其特征是关节炎症.
- 纳米粒子系统为RA治疗提供了有前途的治疗潜力.
- 了解研究趋势对于推进RA纳米疗法至关重要.
研究的目的:
- 分析研究状态,重点领域和RA治疗纳米粒子系统的发展趋势.
- 识别关键出版物,有影响力的研究人员和合作网络.
- 绘制RA纳米医学研究的演变和未来方向.
主要方法:
- 从Web of Science数据库中对2003-2023年期间发表的研究文章进行图书统计分析.
- 对出版成果,地理分布和协作模式的定量分析.
- 使用VOSviewer和Citespace可视化知识地图,以识别关键字,热点和趋势.
主要成果:
- 从2003年到2023年,关于用于RA治疗的纳米粒子系统的出版物显著增加.
- 中国在出版物方面处于领先地位,其次是美国和印度,它们有着积极的国际合作.
- 关键的研究集群包括药物输送系统,黄金纳米颗粒和免疫病理学机制.
结论:
- 基于纳米颗粒的RA治疗研究在过去二十年中大幅扩大.
- 预计未来的研究将集中于阐明RA的病原性机制和开发新的药物输送策略.
- 智能输送系统和新药在RA纳米疗法中显示出高的发展潜力.
相关概念视频
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
Genome-wide Association Studies-GWAS
12.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.2K


